top of page

LINKS TO MEDIA REPORTS OF GROUP AND COLLABORATIVE ACTIVITIES

2024

  • Professor Steve Rannard awarded Macro Group UK Medal - click here

  • University receives Queen’s Anniversary Prize for Chemistry at Palace ceremony - click here

2023

  • Board of Nufarm Ltd visits Liverpool from Australia - click here

2022

  • YouTube - Microparticle collaboration with Nufarm Ltd  - click here

  • RSC Keynote presentation at Lab Innovations 2022 (Birmingham NEC) - click here 

  • Polymer Mimetics webpages at Scott Bader  - click here

2021

  • Materials World - Enduring effects – materials chemistry’s use in long-acting therapeutics - click here 

  • Licensing of LA therapeutics IP to Medicines Patent Pool - click here

  • World AIDS Day: Are long-acting HIV therapies the future? - click here and here

  • New Unilever Radiochemistry Research Fellow - click here

  • Long-acting injectable medicine as potential route to COVID-19 therapy - click here and here

  • Liverpool launches new Centre of Excellence for Long-acting Therapeutics - click here , here and here.

  • Polymer Mimetics opens in Liverpool Science Park - click here and here.

2020

  • University and Scott Bader Company Ltd announce joint venture to develop novel polymer chemistry platform - click here, here, here and here 

  • £24m boost for revolutionary long-acting medicine research - click here

  • Long-acting medicines for malaria, tuberculosis and hepatitis C: Repurposing key medicines as long-acting formulations could revolutionise prevention and treatment - click here and here

2019

  • University spin out company appoints Executive Chairman - click here

  • Novel nano-engineered ‘microneedles’ to help HIV drug delivery - click here

2018

  • £3m boost for Liverpool advanced materials and healthcare research - click here

  • Podcast - Nanomedicine shrinks the cost of HIV treatment - click here to access full podcast

  • Accelerating Material Science Discovery - click here

  • New long-acting approach for malaria prophylaxis developed using nanomedicine approach - click here

  • The Liverpool Model: A revolutionary approach to academic-industry engagement - click here

2017

  • New long-acting approach for malaria prophylaxis developed - click here

  • £2.2m collaboration to develop new approaches for HIV therapy - click here

  • USAID consortium Project OPTIMIZE website - click here

  • First in human trials confirm higher bioavailability from UoL HIV nanomedicines - click here, here and here. Click here and here for CROI 2017 presentation

2016

  • New nanomedicine approach aims to improve HIV drug therapies - click here and here

  • Human PK evaluaion of Efavirenz and Lopinavir Nano-formulations in Healthy Volunteers - click here

 

2015

  • Liverpool partners in first European Nano-Characterisation Laboratory -click here

  • Nanomedicine researchers part of £39m HIV drug therapies consortium - click here; additional reports here and here

  • Outputs, outcomes and impact of MRC research - 2014/15 report - click here

  • University of Liverpool to Licence Patented Solid Drug Nanoparticle Technology to Medicines Patent Pool - click here

  • New partnership paves way for improved HIV tratments through nanomedicine - click here

  • The Medicines Patent Pool (MPP) Signs a Collaborative Agreement with the University of Liverpool to develop HIV Nanomedicines - click here

2014

  • Tracking the effect of revolutionary new medicines - click here

  • Long acting HIV drugs to be developed - click here

  • What nanomedicines will do for us - eventually: Engineering and Technology Magazine - click here

  • Liverpool materials science spin out company launched - click here

  • Nano-sized drug particles to expand HIV treatment further - click here

  • Liverpool represents UK at European nanomedicine day - click here

 

2013

  • Research and Markets: Global Nanotechnology Drug Delivery Market Report 2013-2016: Market to Grow at a CAGR of 74% over 2012-2016 - click here

  • Liverpool scientists to launch groundbreaking nanomedicine research forum at city’s first Knowledge Festival - click here

  • Beating HIV with a nanosized stick - click for RSC link

  • Negating HIV: novel nanomedicines. International Innovation article - click here

  • Webcast of "Enhanced Pharmacological Properties of Efavirenz Formulated as solid drug Nanoparticles" - 20th Conference on Retroviruses and Opportunistic Infections - Altlanta March 2013 - WEBCAST UNAVAILABLE CURRENTLY- click here for conference report

2012

  • Researchers pioneer world’s first HIV/AIDS nanomedicines - click here - EPSRC link

  • Plastic: How it works - BBC 4 TV series - click here and here and here

  • Negating HIV: Novel Nanomedicines- click here

  • Launching the British Society for Nanomedicine - click here

 

2011

  • The Chemistry Innovation KTN Award for Knowledge Transfer - click here

  • IOTA Nanosolutions secures financing for Commercialisation of ContraSol Technology - click here and here

2009

  • University awarded £1.7m to develop nanotechnology for use in healthcare - click here

  • Nano-formulations could reduce pesticide doses - click here

 

2008

  • Opportunities for organic nanoparticles - click here

  • Economic Impact: Spin-out successes - EPSRC Annual Report - click here

  • Nanoparticles Resarch Aids Drug Development - click here

 

2007

  • NorthWest Regional Development Agency Science and Technology Business of the Year & BIONoW Biomedical Startup of the Year: IOTA NanoSolutions - click here

  • IOTA NanoSolutions wins Merseyside Innovation Award - click here and here

  • IOTA Nanosolutions and Liverpool School of Tropical Medicines Announce Collaboration for Next Generation Anti-Malarial Treatments - click here

bottom of page